title: Late-onset blueberry muffin lesions following recombinant erythropoietin administration in a premature infant.
abstract: Recombinant erythropoietin is being used in premature population for anemia of prematurity. It is considered very safe in this population, although risks are still being evaluated. We report the first case of dermal erythropoiesis as a side effect of recombinant erythropoietin in an extremely prematurely born infant presenting with late-onset blueberry muffin lesions.
authors.affiliation: Department of Pediatrics, Division of Neonatology, University of Kansas, School of Medicine, Kansas City, KS, USA. vpandey@kumc.edu
authors.forename: Vishal
authors.initials: V
authors.lastname: Pandey
authors.forename: Krishna
authors.initials: K
authors.lastname: Dummula
authors.forename: Garth
authors.initials: G
authors.lastname: Fraga
authors.forename: Prabhu
authors.initials: P
authors.lastname: Parimi
mesh_terms: D004920:Erythropoiesis / Q000187:drug effects*; D004921:Erythropoietin / Q000009:adverse effects*; D006411:Hematopoiesis, Extramedullary / Q000187:drug effects*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D008297:Male; D011994:Recombinant Proteins / Q000009:adverse effects; D012871:Skin Diseases / Q000139:chemically induced*
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin